“We write to emphasize the urgent need for Congress to take action," the Medical Group Management Association wrote to House and Senate leaders Dec. 19. 

This action comes in response to a lawsuit filed by the Texas Medical Association earlier this year, challenging a 600% increase to this charge.

Telix Pharmaceuticals recently submitted its license application to the FDA for the investigational positron emission tomography agent TLX250-CDx (Zircaix). 
 

The American College of Radiology said it "strongly opposed" the pause and it is currently working with CMS to further fine-tune the system. 

ACR expects the House and Senate to address this issue when lawmakers debate the Continuing Resolution set to expire Jan. 19.

The feds anticipated only about 22,000 disputes between insurers and providers, but the actual number was more than 20 times higher. 

Medical imaging makes up 76% of all the FDA-cleared artificial intelligence clinical algorithms used for direct patient care.

The administration said it is launching a cross-government public inquiry into “corporate greed" in medicine, with roll-up acquisitions one area of focus.